Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-103535

Chief Financial Officer acquired 209,291 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gabay Avraham Chief Financial Officer 2026-09-24 Grant or award +209,291 881,076 D
Loading xslF345X06/ownership.xml…